Teladoc Health: Expected Slowdown
Despite (TDOC) forecasting that business will still top the COVID-19 boost in most metrics, the stock is falling by nearly 10%. The telehealth provider is forecasting a major slowdown in new members and total visit growth for the year as the company faces tough comps. My investment thesis remains bearish on the stock for now.
Read the full article on Seeking Alpha.
Update - May 6
The stock for Teladoc Health continues to be line with more and more competition. First, Amwell (AMWL) apparently took Pepsi as a customer and now Walmart (WMT) is buying a competitor.
Investors should avoid Teladoc Health until all of this shakes out and competition is no longer interested in joining the telehealth race.
Disclosure: No position mentioned. Please review the disclaimer page for more details.